Linux Laboratories
Type
investor
Founded
2007
Funding Rounds
0
Portfolio companies
0
About Linux Laboratories
Linux Laboratories is a multinational pharmaceutical company focused on branded and specialty generic medicines, with particular strength in neuropsychiatry and central nervous system therapies. Its portfolio also spans critical care, dermatology, nutraceuticals, and cardio-diabetic treatments. The company develops and acquires pharmaceutical brands, manufactures products at WHO-GMP-certified facilities, provides contract manufacturing services, and exports to international markets, emphasizing accessible, affordable medicines for healthcare professionals and patients.
Linux Laboratories funding captured (1)
| Deal type | Stage | Date | Amount | Investors |
|---|---|---|---|---|
| Hybrid | Unspecified | Oct 3, 2026 | $70.0m |